(1888PressRelease)
November 07, 2009 - For the first time in the history of WHO, an opportunity to reinforce comprehensive cancer policies and strategies among its member states has presented itself. This resolution was adopted cancer prevention and control resolution, May 2005
The 58th World Health Assembly resolution on cancer prevention and control (WHA58.22) adopted in May 2005, calls on Member States to intensify action against cancer by developing and reinforcing cancer control programs. This is being done by implementing the four components of cancer control: prevention, early detection, diagnosis & treatment and palliative care. (Source Resolution on Cancer Control WHA58.22 ENGLISH)
"I reflect on my time underwriting this project. I have to say that it was something that I wanted to take on myself; whether I am an executive officer or not it is really irrelevant. When issues come up like this, you want to be part of it." Said the Vice President of Knight Investments LLC .
Who couldn't have thought of a better way to promote health, but by taking into a project that helps the cancer cause's search for a cure.
The Canadian based biotechnology company, will advance the development of its innovative anticancer agent Aimpila which uses a proprietary carrier known as Alpha-fetoprotein (AFP) being specific to cancer cells. This technology platform makes anticancer medicine more effective in treating cancer and less toxic for cancer patients. The technology developed by Constab can be used to develop new medicine that would be less costly and benefit a greater number of people worldwide including those with lower revenues.
"This is a great advance for cancer treatment. I know a person who has cancer and I think it's so wonderful to see these type of things come to pass." said Jazline Cruz, a young woman who worked in the health services of Sanford FL.
That's exactly what Knight Investments LLC intends to do by taking projects like these to go through their compliance process. The project size is an estimated 13 million USD project that will help assist the development of this new technology and catapult the Canadian based company to the arena where it can help people the most.
"Dr. Mark Vincent, oncologist at the London Cancer Centre, is also very supportive of the technology and believes in its potential. " said Mr. Gagne, President of the Canadian Based Company.
Dr. Mark Vincent in his press release interview had this to say, "This medicine complex certainly deserves further pre-clinical and bioavailability studies, followed by studies of larger patient groups in standardized, early phase clinical trials”.
Dr. Vincent has agreed to be a co-presenter at the ASCO meeting in Chicago.
With promotion of health, green technology, feeding hungry children, and company principal contributions to organizations like Christian Children's Fund; it's only a matter of time before Knight Investments LLC can make a positive impact on this world.
Knight Investments LLC works as a private equity firm to invest personal funds on the behalf and promotion of a vibrant community, low income housing, humanitarian causes, renewable energies, real estate developments, and project financing.
###
